CO5280153A1 - ANTIGEN ASSOCIATED WITH TUMORS (R11) - Google Patents

ANTIGEN ASSOCIATED WITH TUMORS (R11)

Info

Publication number
CO5280153A1
CO5280153A1 CO00058185A CO00058185A CO5280153A1 CO 5280153 A1 CO5280153 A1 CO 5280153A1 CO 00058185 A CO00058185 A CO 00058185A CO 00058185 A CO00058185 A CO 00058185A CO 5280153 A1 CO5280153 A1 CO 5280153A1
Authority
CO
Colombia
Prior art keywords
antigen associated
tumors
seq
fragment
presents
Prior art date
Application number
CO00058185A
Other languages
Spanish (es)
Inventor
Konopitzky Renate
Koenig Ulrich
Wolfgang Sommergruber
Thomas Woelfel
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of CO5280153A1 publication Critical patent/CO5280153A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • Neurology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

1.- Molécula aislada de ADN que presenta la secuencia de nucleótidos representada en SEQ ID No. 1 o un polinucleótido, que se hibrida con esta molécula de ADN en condiciones rigurosas, o un fragmento de éste.4.- Antígeno asociado con tumores con la denominación R11-ORF-1, caracterizado porque presenta La secuencia de aminoácidos definida en SEQ ID NO: 2 o contiene a ésta como secuencio parcial.5.- Fragmento de proteína o péptido inmunógeno, caracterizado porque se deriva del antígeno asociado con un tumor, que se define en la reivindicación 4.1.- Isolated DNA molecule that presents the nucleotide sequence represented in SEQ ID No. 1 or a polynucleotide, which hybridizes with this DNA molecule under stringent conditions, or a fragment thereof.4.- Antigen associated with tumors with the designation R11-ORF-1, characterized in that it presents the amino acid sequence defined in SEQ ID NO: 2 or contains it as a partial sequence.5.- Fragment of immunogenic protein or peptide, characterized in that it is derived from the antigen associated with a tumor , which is defined in claim 4.

CO00058185A 1999-08-04 2000-08-02 ANTIGEN ASSOCIATED WITH TUMORS (R11) CO5280153A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19936563A DE19936563A1 (en) 1999-08-04 1999-08-04 Tumor Associated Antigen

Publications (1)

Publication Number Publication Date
CO5280153A1 true CO5280153A1 (en) 2003-05-30

Family

ID=7917065

Family Applications (1)

Application Number Title Priority Date Filing Date
CO00058185A CO5280153A1 (en) 1999-08-04 2000-08-02 ANTIGEN ASSOCIATED WITH TUMORS (R11)

Country Status (9)

Country Link
EP (1) EP1206535A1 (en)
JP (1) JP2003506085A (en)
AU (1) AU6278300A (en)
CA (1) CA2383230A1 (en)
CO (1) CO5280153A1 (en)
DE (1) DE19936563A1 (en)
MX (1) MXPA02001137A (en)
UY (1) UY26266A1 (en)
WO (1) WO2001011040A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8258260B2 (en) 1970-02-11 2012-09-04 Immatics Biotechnologies Gmbh Tumor-associated peptides binding promiscuously to human leukocyte antigen (HLA) class II molecules
US8212000B2 (en) 1970-02-11 2012-07-03 Immatics Biotechnologies Gmbh Tumor-associated peptides binding promiscuously to human leukocyte antigen (HLA) class II molecules
US8211999B2 (en) 1970-02-11 2012-07-03 Immatics Biotechnologies Gmbh Tumor-associated peptides binding promiscuously to human leukocyte antigen (HLA) class II molecules
JP2003093066A (en) * 2001-09-21 2003-04-02 Univ Tokyo Method for controlling proliferation and apoptosis of carcinoma cell
WO2003063770A2 (en) 2001-11-07 2003-08-07 Mannkind Corporation Expression vectors encoding epitopes of target-associated antigens and methods for their design
DE10211088A1 (en) * 2002-03-13 2003-09-25 Ugur Sahin Gene products differentially expressed in tumors and their use
US20050221350A1 (en) 2002-05-29 2005-10-06 Toni Weinschenk Method for identifying immunoreactive peptides
DE10225144A1 (en) 2002-05-29 2003-12-18 Immatics Biotechnologies Gmbh Tumor-associated peptides binding to MHC molecules
DE10341812A1 (en) * 2003-09-10 2005-04-07 Ganymed Pharmaceuticals Ag Differentially expressed in tumors gene products and their use
DE102005041616B4 (en) * 2005-09-01 2011-03-17 Johannes-Gutenberg-Universität Mainz Melanoma associated MHC class I associated oligopeptides and polynucleotides encoding them and their uses
PT1760088E (en) 2005-09-05 2008-05-14 Immatics Biotechnologies Gmbh Tumor-associated peptides binding promiscuously to human leukocyte antigen (hla) class ii molecules
WO2010052244A1 (en) 2008-11-05 2010-05-14 Morphosys Ag Deconvolution method

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69837273T2 (en) * 1997-10-08 2008-01-31 The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services HUMAN CANCER ANTIBODY NY ESO-1 / CAG-3 AND GENEAN CODING THEREFOR
CA2383592A1 (en) * 1999-03-31 2000-10-05 Curagen Corporation 2384891 acids including open reading frames encoding polypeptides; orfx

Also Published As

Publication number Publication date
EP1206535A1 (en) 2002-05-22
CA2383230A1 (en) 2001-02-15
WO2001011040A1 (en) 2001-02-15
JP2003506085A (en) 2003-02-18
DE19936563A1 (en) 2001-02-08
UY26266A1 (en) 2001-01-31
MXPA02001137A (en) 2002-11-04
AU6278300A (en) 2001-03-05

Similar Documents

Publication Publication Date Title
CY1109978T1 (en) ANTIGONIC PELLETS EXPORTED FROM TELOMERAS
CO5280153A1 (en) ANTIGEN ASSOCIATED WITH TUMORS (R11)
WO2001005422A3 (en) Use of a polypeptide for detecting, preventing or treating a pathological condition associated with a degenerative, neurological or autoimmune disease
AU4778101A (en) Novel polypeptides, and nucleic acids encoding the same
CO4850588A1 (en) PROSTATE CANCER IMMUNOTHERAPY COMPOUNDS.
AP9701163A0 (en) Streptococcal heat shock proteins members of the HSP70 family.
WO2002029086A3 (en) Nucleic acid sequences differentially expressed in cancer tissue
ATE399858T1 (en) FLOWER ORGAN-SPECIFIC PROMOTER SEQUENCES
NO984415D0 (en) Peptides with antiproliferative properties
GB0202556D0 (en) Novel Protein
EP1536006A4 (en) Cancer antigens and utilization thereof
JP2002517193A5 (en)
CA2412783A1 (en) Vaccine against cancerous diseases associated with the her-2/neu oncogene
PE20000759A1 (en) CYTOCHROME HYDROQUINONE OXIDASE GENE OF TYPE BD
CA2411249A1 (en) Gasc1 gene
CO5280140A1 (en) ANTIGEN (C42) ASSOCIATED WITH TUMORS
ATE382634T1 (en) NULEOTIDE SEQUENCES THAT CODE FOR THE CITA GENE
CA2311646A1 (en) Tsa305 gene
DE60036676D1 (en) G-PROTEIN-COUPLED RECEPTOR-SIMILAR PROTEINS
DE69827880D1 (en) IGA1-PROTEASE FRAGMENT AS CARRIER PEPTIDE
AU2456600A (en) The ltr region of msrv-1 and the proteins it encodes, and probes and methods fordetecting msrv-1 retrovirus
CA2397789A1 (en) Novel human kinase protein and polynucleotides encoding the same
NZ512308A (en) Chlamydia antigens and corresponding DNA fragments and uses thereof
CO5400145A1 (en) PROTEIN ASSOCIATED WITH DISEASE
TH55514B (en) Nucleotide sequence with code for China ccpA1

Legal Events

Date Code Title Description
FA Application withdrawn